Thoracic Neoplasm — Trials

Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,160 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 2,040 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06667076	A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)(COPERNICUS)	recruiting	Phase 2	480	Janssen Research & Development, LLCINDUSTRY	14	Sep 25, 2026	clinicaltrials
NCT06667908	A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)(CONVERGE)	recruiting	Phase 2	130	Johnson & Johnson Enterprise Innovation Inc.